Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC

Patients with CNLC IIIb hepatocellular carcinoma will receive hepatectomy. Two to four weeks later, they will receive camrelizumab and apatinib treatments.